Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design

BACKGROUND: Following universal recommendation for use of 13-valent pneumococcal conjugate vaccine (PCV13) in US adults aged ≥65 years in September 2014, we conducted the first real-world evaluation of PCV13 vaccine effectiveness (VE) against hospitalized vaccine-type community-acquired pneumonia (C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: McLaughlin, John M, Jiang, Qin, Isturiz, Raul E, Sings, Heather L, Swerdlow, David L, Gessner, Bradford D, Carrico, Ruth M, Peyrani, Paula, Wiemken, Timothy L, Mattingly, William A, Ramirez, Julio A, Jodar, Luis
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206101/
https://ncbi.nlm.nih.gov/pubmed/29790925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy312
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados